Balyasny Asset Management
ASXC

Balyasny Asset Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Balyasny Asset Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,138
Closed -$16K – 3356
2022
Q2 		$16K Buy
+40,138
New +$17.9K ﹤0.01% 2514
2019
Q2 		– Sell
-5,953
Closed -$184K – 1789
2019
Q1 		$184K Sell
5,953
-8,051
-57% -$270K ﹤0.01% 1355
2018
Q4 		$411K Buy
14,004
+7,065
+102% +$321K ﹤0.01% 1145
2018
Q3 		$523K Sell
6,939
-10,396
-60% -$703K ﹤0.01% 1364
2018
Q2 		$983K Buy
17,335
+16,404
+1,762% +$597K ﹤0.01% 1140
2018
Q1 		$21K Buy
+931
New +$21.3K ﹤0.01% 1878
2016
Q2 		– Sell
-983
Closed -$54K – 1504
2016
Q1 		$54K Buy
+983
New +$42.1K ﹤0.01% 1228

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Balyasny Asset Management's ASXC Position: Q3 2022 in Review

Balyasny Asset Management sold out of Asensus Surgical, Inc. (ASXC) in Q3 2022, closing a stake of 40,138 shares — an estimated $16K sold.

Balyasny Asset Management first reported a position in ASXC in Q1 2016 and held it in 7 quarters. The position peaked at $983K in Q2 2018. 82 funds tracked by Wall St. Rank hold ASXC as of Q3 2022.

  • Balyasny Asset Management reported no remaining Asensus Surgical, Inc. position as of Q3 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 40,138 Asensus Surgical, Inc. shares in Q3 2022, an estimated $16K.
  • Balyasny Asset Management first reported a position in Asensus Surgical, Inc. in Q1 2016 and held it in 7 quarters.
  • Balyasny Asset Management's Asensus Surgical, Inc. position peaked at $983K in Q2 2018.
  • 82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.